Transplantasi Sel Punca Haploidentik Dokter Terbaik di Israel - TOP-14 dokter

Dr. Ram Ron berspesialisasi dalam Transplantasi Sel Punca Haploidentik di Sourasky Medical Center (Ichilov).

• Pengalaman lebih dari 25 tahun di bidang tersebut
• Menjalani pelatihan Fellowship di Ronald O Perelman and Claudia Cohen Centre
• Berspesialisasi dalam teknik kedokteran reproduksi yang kompleks

300+ transplantasi sel punca – Dr. Ronit El Hasid memimpin onkohematologi pediatrik di Rumah Sakit Anak Dana Dwek, yang merupakan pemimpin di bidang tersebut.

• Berspesialisasi dalam transplantasi sumsum tulang dan darah tali pusat untuk anak-anak
• Telah menerbitkan 50 makalah penelitian dan 40 laporan konferensi
• Menjalani pelatihan di City of Hope Hospital di Los Angeles
• Anggota American Hematology Association

Dr. Ron Ram telah melakukan beberapa ratus transplantasi sel punca di Sourasky Medical Center, berspesialisasi dalam prosedur haploidentik.

• Bersertifikat dewan (Board-certified) dalam Penyakit Dalam, Hematologi, dan Onkologi Medis
• Menyelesaikan program fellowship dalam Hematologi dan Onkologi di New York Medical College
• Menerbitkan lebih dari 30 artikel ilmiah tentang hematologi dan onkologi
• Menyumbangkan satu bab untuk buku teks kedokteran

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira berspesialisasi dalam Transplantasi Sumsum Tulang di Pusat Medis Sourasky (Ichilov), dengan pengalaman luas dalam prosedur sel punca haploidentik.

• Lulus dari Fakultas Kedokteran Universitas Ibrani pada tahun 1999
• Mengambil spesialisasi dalam penyakit dalam di Pusat Medis Hadassah
• Dokter senior di departemen Transplantasi Sumsum Tulang di Hadassah
• Fasih berbahasa Inggris dan Ibrani untuk komunikasi dengan pasien

Dengan 31 tahun dedikasi pada onkohematologi, Dr. Aviv berspesialisasi dalam gangguan darah kompleks di Pusat Medis Sourasky (Klinik Ichilov).

• Berspesialisasi dalam transplantasi sel punca haploidentik
• Pengalaman luas dengan kasus langka dan menantang
• Bekerja di pusat medis terkemuka di Israel

Dr. Dror Levin berspesialisasi dalam perawatan inovatif untuk kelainan darah pediatrik dan kanker tulang, berfokus pada kasus-kasus kompleks di Sourasky Medical Center.

• Direktur hematologi onkologi pediatrik di Sourasky Medical Center
• Anggota Israel Society of Pediatric Hematology-Oncology (ISPHO)
• Pelatihan di institusi terkemuka termasuk Rizzoli Orthopaedic Institute di Italia
• Mengkoordinasikan perawatan untuk kanker tulang (sarkoma) pada anak-anak

Pakar terkemuka dalam leukemia limfositik kronis – Dr. Herishanu Yair telah menerima berbagai penghargaan untuk penelitian hematologi dan pekerjaan klinisnya.

• Ahli hematologi bersertifikat dewan (board-certified) dengan pengalaman lebih dari 20 tahun
• Penerima Klitzberg Oncology Award dari American Physician Fellowship
• Anggota dari Asosiasi Hematologi Israel dan Amerika
• Mendapatkan pelatihan di pusat medis terkemuka termasuk Pusat Medis Tel Aviv

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.